Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 4974-4978

  Walter, Steffen ^a   Herrgen, Leah ^a   Schoor, Oliver ^a   Jung, Gundram ^a   Wernet, Dorothee ^a   Bühring, Hans Jörg ^a   Rammensee, Hans Georg ^a   Stevanović, Stefan ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Institute for Cell Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD28 ANTIBODY; CD28 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; MICROSPHERE; UNCLASSIFIED DRUG; VACCINE;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0242495753     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.4974     Document Type: Article

References (18)

1. Celis, E., V. Tsai, C. Crimi, R. DeMars, P. A. Wentworth, R. W. Chesnut, H. M. Grey, A. Sette, and H. M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91:2105.
2. Dudley, M. E., J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu, D. J. Schwartzentruber, S. L. Topalian, R. Sherry, N. P. Restifo, A. M. Hubicki, et al. 2002. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850.
3. Latouche, J. B., and M. Sadelain. 2000. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nat. Biotechnol. 18:405.
4. Goldstein, S. A., and M. F. Mescher. 1986. Cell-sized, supported artificial membranes (pseudocytes): response of precursor cytotoxic T lymphocytes to class I MHC proteins. J. Immunol. 137:3383.
5. Motta, I., Y. C. Lone, and P. Kourilsky. 1998. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density. Eur. J. Immunol. 28:3685.
6. + T cells via signal 1 alone. J. Immunol. 161:5226.
7. + T cells. J. Immunol. 162:3256.
8. Oelke, M., M. V. Maus, D. Didiano, C. H. June, A. Mackensen, and J. P. Schneck. 2003. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat. Med. 9:619.
9. Alexander-Miller, M. A., G. R. Leggatt, and J. A. Berzofsky. 1996. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93:4102.
10. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213.
11. Altman, J. D., P. A. Moss, P. J. Gouldet, D. H. Batouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
12. Jung, G., J. A. Ledbettet, and H. J. Muller-Eberhard. 1987. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. Proc. Natl. Acad. Sci. USA 84:4611.
13. Hilf, N., H. Singh-Jasuja, P. Schwarzmaier, C. Gouttefangeas, H. G. Rammensee, and H. Schild. 2002. Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 99:3676.
14. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 190:705.
15. + lymphocytes as compared with nonprofessional APC. J. Immunol. 167:1188.
16. Wilson, C. C., W. C. Olson, T. Tuting, C. R. Rinaldo, M. T. Lotze, and W. J. Storkus. 1999. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines. J. Immunol. 162:3070.
17. Yee, C., P. A. Savage, P. P. Lee, M. M. Davis, and P. D. Greenberg. 1999. Isolation of high avidity melanoma-teactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:2227.
18. Dutoit, V., V. Rubio-Godoy, M. A. Doucey, P. Batard, D. Lienard, D. Rimoldi, D. Speiser, P. Guillaume, J. C. Cerottini, P. Romero, and D. Valmori. 2002. Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR. J. Immunol. 168:1167.